InvestorsHub Logo
Followers 86
Posts 12714
Boards Moderated 0
Alias Born 10/12/2010

Re: Carboat post# 264758

Monday, 05/23/2016 10:34:50 PM

Monday, May 23, 2016 10:34:50 PM

Post# of 345843
The FDA says that the Sunrise study is still ongoing and has not failed so can you please provide a link that says the study has been finalized ? If you can't provide such link.... then its in everyone best interest to wait for the final results, because the FDA can conclude that the control arm had provisions built into the trial that IF patients were lured out of Sunrise for another drug such as Opdivo (that manipulated the trial comparator control drug of Docetaxel, THEN there could be provisions to modify the control arm and use historic Docetaxel MOS results vs the Bavituximab+Docetaxel arm that "PERFORMED AS EXPECTED" : )

This study is ongoing, but not recruiting participants.

Sponsor:
Peregrine Pharmaceuticals
Information provided by (Responsible Party):
Peregrine Pharmaceuticals

https://clinicaltrials.gov/ct2/show/NCT01999673?term=sunrise+bavituximab&rank=1


"Bavituximab is a first-in-class phosphatidylserine (PS)-targeting monoclonal antibody that is the cornerstone of a broad clinical
pipeline."
-- Big Pharmas nightmare... unless they are fortunate enough to have The Bavi Edge!

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News